阿布昔替尼成功治疗10个指甲严重甲营养不良1例

doi:10.35541/cjd.20230522

中华皮肤科杂志 ›› 2024, e20230522.doi: 10.35541/cjd.20230522

阿布昔替尼成功治疗10个指甲严重甲营养不良1例

范梅娜陆迎炜冯雨苗丁高中孙澜马伟

南京医科大学附属苏州医院苏州市立医院东区皮肤科，苏州 215000

收稿日期:2023-09-08 修回日期:2024-03-14 发布日期:2024-05-16
通讯作者: 孙澜；马伟 E-mail:slszsy@126.com; maweitongxing@163.com

A case of severe ten-nail onychodystrophy successfully treated with abrocitinib

Fan Meina, Lu Yingwei, Feng Yumiao, Ding Gaozhong, Sun Lan, Ma Wei

Department of Dermatology, the Affiliated Suzhou Hospital of Nanjing Medical University, East District of Suzhou Municipal Hospital, Suzhou 215000, Jiangsu, China

Received:2023-09-08 Revised:2024-03-14 Published:2024-05-16
Contact: Sun Lan; Ma Wei E-mail:slszsy@126.com; maweitongxing@163.com

摘要/Abstract

摘要： 患者女，45岁，因双手拇指甲变形8年、其余指甲变形2年于2020年6月15日就诊。8年前患者无明显诱因双手拇指甲开始出现横嵴，自觉拇指甲周皮肤瘙痒不适，不自主搔抓，未予重视……

范梅娜陆迎炜冯雨苗丁高中孙澜马伟. 阿布昔替尼成功治疗10个指甲严重甲营养不良1例[J]. 中华皮肤科杂志, 2024,e20230522. doi:10.35541/cjd.20230522

Fan Meina, Lu Yingwei, Feng Yumiao, Ding Gaozhong, Sun Lan, Ma Wei. A case of severe ten-nail onychodystrophy successfully treated with abrocitinib[J]. Chinese Journal of Dermatology,2024,e20230522. doi:10.35541/cjd.20230522

参考文献 10

［1］	Chng WQ, Yew YW. Nail manifestations in atopic dermatitis: a systematic review［J］. Int J Dermatol, 2020,59（6）:670⁃676. doi: 10.1111/ijd.14726.
［2］	Hur K, Han B, Lim SS, et al. Histopathologic findings of idiopathic trachyonychia: an analysis of 30 adult patients［J］. J Cutan Pathol, 2021,48（3）:396⁃402. doi: 10.1111/cup.13909.
［3］	Clark A, Jellinek NJ. Intralesional injection for inflammatory nail diseases［J］. Dermatol Surg, 2016,42（2）:257⁃260. doi: 10.1097/DSS.0000000000000621.
［4］	Merola JF, Elewski B, Tatulych S, et al. Efficacy of tofacitinib for the treatment of nail psoriasis: two 52⁃week, randomized, controlled phase 3 studies in patients with moderate⁃to⁃severe plaque psoriasis［J］. J Am Acad Dermatol, 2017,77（1）:79⁃87.e1. doi: 10.1016/j.jaad.2017.01.053.
［5］	Chelidze K, Lipner SR. Nail changes in alopecia areata: an update and review［J］. Int J Dermatol, 2018,57（7）:776⁃783. doi: 10.1111/ijd.13866.
［6］	Dube V, Bhushan R. Tofacitinib for the treatment of twenty⁃nail dystrophy: a single case report［J］. Indian J Dermatol, 2022,67（6）:725⁃727. doi: 10.4103/ijd.ijd_492_22.
［7］	Iorizzo M, Haneke E. Tofacitinib as treatment for nail lichen planus associated with alopecia universalis［J］. JAMA Dermatol, 2021,157（3）:352⁃353. doi: 10.1001/jamadermatol.2020.4555.
［8］	Bauman JN, Doran AC, King⁃Ahmad A, et al. The pharmacokinetics, metabolism, and clearance mechanisms of abrocitinib, a selective Janus kinase inhibitor, in humans［J］. Drug Metab Dispos, 2022,50（8）:1106⁃1118. doi: 10.1124/dmd. 122.000829.
［9］	Lugović⁃Mihić L, Meštrović⁃Štefekov J, Potočnjak I, et al. Atopic dermatitis: disease features, therapeutic options, and a multidisciplinary approach［J］. Life （Basel）, 2023,13（6）:1419. doi: 10.3390/life13061419.
［10］	Tominaga M, Takamori K. Peripheral itch sensitization in atopic dermatitis［J］. Allergol Int, 2022, 71（3）:265⁃277. doi: 10.1016/j.alit.2022.04.003.

阿布昔替尼成功治疗10个指甲严重甲营养不良1例

A case of severe ten-nail onychodystrophy successfully treated with abrocitinib

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 10

相关文章 0

Metrics

本文评价

推荐阅读 10